0000950170-24-001364.txt : 20240103 0000950170-24-001364.hdr.sgml : 20240103 20240103194005 ACCESSION NUMBER: 0000950170-24-001364 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231203 FILED AS OF DATE: 20240103 DATE AS OF CHANGE: 20240103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: HUFF CURTIS W CENTRAL INDEX KEY: 0001250127 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41403 FILM NUMBER: 24509228 MAIL ADDRESS: STREET 1: 4510 LAMESA HWY CITY: SNYDER STATE: TX ZIP: 79549 FORMER NAME: FORMER CONFORMED NAME: HUFT CURTIS W DATE OF NAME CHANGE: 20030628 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Freebird Investments LLC CENTRAL INDEX KEY: 0001971406 ORGANIZATION NAME: STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41403 FILM NUMBER: 24509229 BUSINESS ADDRESS: STREET 1: 2800 POST OAK BLVD., SUITE 2000 CITY: HOUSTON STATE: TX ZIP: 77056 BUSINESS PHONE: 713-961-0118 MAIL ADDRESS: STREET 1: 2800 POST OAK BLVD., SUITE 2000 CITY: HOUSTON STATE: TX ZIP: 77056 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Freebird Partners LP CENTRAL INDEX KEY: 0001955231 ORGANIZATION NAME: STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41403 FILM NUMBER: 24509230 BUSINESS ADDRESS: STREET 1: 2800 POST OAK BLVD. STREET 2: SUITE 2000 CITY: HOUSTON STATE: TX ZIP: 77056 BUSINESS PHONE: 713-961-0118 MAIL ADDRESS: STREET 1: 2800 POST OAK BLVD. STREET 2: SUITE 2000 CITY: HOUSTON STATE: TX ZIP: 77056 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Comera Life Sciences Holdings, Inc. CENTRAL INDEX KEY: 0001907685 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 874706968 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (617)871-2101 MAIL ADDRESS: STREET 1: 12 GILL STREET STREET 2: SUITE 4650 CITY: WOBURN STATE: MA ZIP: 01801 3 1 ownership.xml 3 X0206 3 2023-12-03 0 0001907685 Comera Life Sciences Holdings, Inc. CMRA 0001955231 Freebird Partners LP 2800 POST OAK BLVD, SUITE 2000 HOUSTON TX 77056 false false true false 0001971406 Freebird Investments LLC 2800 POST OAK BLVD, SUITE 2000 HOUSTON TX 77056 false false true false 0001250127 HUFF CURTIS W 2800 POST OAK BLVD, SUITE 2000 HOUSTON TX 77056 false false true false Common Stock, par value $0.0001 per share 1254776 D Common Stock Purchase Warrant 1.23 2023-01-04 2028-01-04 Common Stock, par value $0.0001 per share 743242 D Common Stock Purchase Warrant 0.6135 2024-02-01 2028-07-31 Common Stock, par value $0.0001 per share 1198044 D Common Stock Purchase Warrant 0.6135 2023-09-11 2028-09-11 Common Stock, par value $0.0001 per share 513447 D This report is filed jointly by Freebird Partners LP, a Texas limited partnership ("Freebird Partners"), Freebird Investments LLC, a Texas limited liability company ("Freebird Investments"), and Curtis W. Huff (each a "Reporting Person" and collectively, the "Reporting Persons") in connection with their respective direct and indirect ownership of common stock, par value $0.0001 ("Common Stock") of Comera Life Sciences Holdings, Inc. (the "Company"). These securities of the Company are held of record by Freebird Partners. Freebird Investments serves as the general partner of Freebird Partners. Curtis W. Huff is the sole member of Freebird Investments. By virtue of these relationships, each of Freebird Investments and Mr. Huff may be deemed to share beneficial ownership of the securities held of record by Freebird Partners. Pursuant to that certain Securities Purchase Agreement dated January 2, 2023, the Company issued that certain Common Stock Purchase Warrant ("Warrant") to Freebird Partners LP, in substantially the form as the form of warrant filed as Exhibit 4.1 to the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission (the "SEC") on January 4, 2023. The Warrant became exercisable on January 4, 2023, and may be exercised through January 4, 2028, at an exercise price of $1.23 per share of Common Stock. Pursuant to that certain Securities Purchase Agreement dated July 31, 2023, the Company issued that certain Common Stock Purchase Warrant ("First Warrant") to Freebird Partners LP on July 31, 2023, in substantially the form as the form of warrant filed as Exhibit 4.1 to the as announced in the Issuer's Current Report on Form 8-K filed with the SEC on August 1, 2023. The First Warrant becomes exercisable on February 1, 2024, and may be exercised through July 31, 2028, at an exercise price of $0.6135 per share of Common Stock. Pursuant to that certain Securities Purchase Agreement dated July 31, 2023, the Company issued that certain Common Stock Purchase Warrant ("Second Warrant") to Freebird Partners LP on September 11, 2023, in substantially the form as the form of warrant filed as Exhibit 4.1 to the as announced in the Issuer's Current Report on Form 8-K filed with the SEC on August 1, 2023. The Second Warrant became exercisable on September 11, 2023, and may be exercised through September 11, 2028, at an exercise price of $0.6135 per share of Common Stock. Freebird Partners LP, By: Freebird Investments LLC, its general partner, By: /s/ Curtis W. Huff, Chairman and President 2024-01-03 Freebird Investments LLC, By: /s/ Curtis W. Huff, Chairman and President 2024-01-03 /s/ Curtis W. Huff 2024-01-03